UTEST company makes cameo through launch of OneEleven, Toronto’s new data-driven accelerator for entrepreneurs
CBC’s Lang & O’Leary Exchange featured Granata Decision Systems, one of the first UTEST companies incubated through that program for early-stage technologies by MaRS Innovation and the University of Toronto, in their program on Wednesday, November 28, 2013.
The data-driven company is one of eight to join the inaugural cohort for OneEleven, a new accelerator funded by OMERS Ventures, the Ontario Centres of Excellence, Ryerson University and other industry partners to support mature, sophisticated entrepreneurs tackling big data problems.
Indiegogo campaign to raise funds for North American clinical study during Breast Cancer Awareness Month; 12 artists donate 13 original works worth over $15,000 to support campaign
Toronto, Canada (October 9, 2013) — WaveCheck— a painless, non-surgical clinical technique developed by a Sunnybrook Health Sciences Centre oncologist and a Ryerson University physicist and supported by MaRS Innovation — is poised to transform chemotherapy response monitoring for women with breast cancer.
WaveCheck combines traditional ultrasound with new software to detect responses to chemotherapy in breast cancer tissues. By making better, more accurate information available about a woman’s response to her chemotherapy treatment in weeks rather than months, WaveCheck creates greater transparency through dialogue between a women and her doctors, empowering her to participate in discussions about whether a given chemotherapy treatment is effective.
Contribute to WaveCheck‘s Indiegogo campaign and help make this technology available to all women with breast cancer faster.
Developed by Dr. Gregory Czarnota, chief of Radiation Oncology at Sunnybrook’s Odette Cancer Centre, and Michael C. Kolios, professor of Physics and Canada Research Chair in Biomedical Applications of Ultrasound at Ryerson, WaveCheck has been used in clinical studies with nearly 100 women receiving upfront, neoadjuvant chemotherapy to treat locally-advanced breast cancer. These results are published in two leading journals, Clinical Cancer Research and Translational Oncology.
In the Indiegogo campaign video, Czarnota, Kolios and three of the 100 women who participated in the first Sunnybrook study explain WaveCheck’s impact.
“The hard truth for women with breast cancer is that 60 to 70 per cent of chemotherapy treatments fail,” said Czarnota, who is also a senior scientist and director of cancer research at Sunnybrook Research Institute and assistant professor in the University of Toronto’s Departments of Radiation Oncology and Medical Biophysics within the Faculty of Medicine. “The 1.5 million women worldwide who will be diagnosed with breast cancer this year need to know that their chemotherapy is working as soon as possible. But this kind of treatment monitoring doesn’t currently exist in standard clinical practice. Instead, a woman’s tumour response is evaluated after she completes her chemotherapy treatment, which is typically a four- to six-month process.
10,000 Indiegogo supporters first to try one-dimensional, virtual mobile keyboard
TORONTO, Canada (June 18, 2013) — Whirlscape Inc., creators of Minuum, “the little keyboard for big fingers,” today released the Android beta to the nearly 10,000 supporters who funded the keyboard’s wildly successful Indiegogo campaign.
The Minuum Project campaign raised over $87,000 (USD) through the crowdfunding platform between March and April 2013, well past its initial goal of $10,000. Whirlscape promised to release the hotly anticipated Minuum beta two months after the campaign, and has delivered on that promise.
Minuum’s beta launch to its Indiegogo supporters was covered by TechCrunch, TechCrunch Japanand Mobile Syrup. Whirlscape’s technology was also highlighted in a VentureBeat article on the future of typing.
The product was also reviewed on TechVibes and the Android Police blog: “Minuum Keyboard Beta: Good enough to renew my faith in crowd-funded campaigns.”
Minuum is a tiny, linear,one-dimensional touchscreen keyboard that re-imagines the standard QWERTY layout. It frees up mobile screen space while allowing fast, accurate typing. This touchscreen keyboard marks the first phase of the Minuum Project, which seeks to simplify typing on mobile devices—such as smartphones and tablets—and enable typing for wearable technology. The beta release is an important first step towards Minuum’s “type anywhere” future.
MI’s Fanny Sie and Shotlst Co-founder Matt Ratto talk bioprinting, healthcare, civil rights and home manufacturing with Steve Paikin
Fanny Sie, project manager in physical sciences and medical devices with specialization in medical imaging, appeared on TVO’s The Agenda on June 5, 2013 to discuss 3D printing.
Sie manages the Bioprinter technology, which was touched upon during the interview. The bioprinter was invented by Axel Guenther, a professor in the University of Toronto’s Department of Mechanical and Industrial Engineering, PhD student Lian Leng and a team of other researchers.
The Globe and Mail covered the Bioprinter’s development on January 20, 2013; an excerpt of their interviews with Leng and Guenther was included in the program.
Bioprinting and the Internet of Things
The Agenda’s 3D printing episode also included a second segment exploring its implications for home manufacturing and civil liberties. The guests included Matt Ratto, assistant professor in U of T’s Faculty of Information and co-inventor and CEO of Shotlst (a UTEST company).
Professor Matt Ratto, co-founder of Shotlst and director of the Critical Making Lab, discusses 3D printing, home manufacturing and civil liberties on TVO’s The Agenda.
Ratto described his experience downloading and printing the Liberator, a gun that can be printed using 3D printing technology, to better understand the process required and the resulting gun’s capabilities.
Over 9,600 people funded Toronto start-up’s one-dimensional mobile keyboard
TORONTO, Canada (April 18, 2013) — The Indiegogo campaign for Minuum, “the little keyboard for big fingers,” created by Whirlscape Inc., has closed after raising $87,369 in one month.
Minuum is a one-dimensional, tiny keyboard that frees up mobile screen space while allowing fast, accurate typing. Its specialized, patent-protected auto-correction algorithm allows highly imprecise typing, configuring the difference between what you type and what you mean in real time and getting it right even if you miss every single letter.
The campaign’s initial goal — $10,000 to fund the launch of an Android keyboard app — was reached within 14 hours. Since its launch on March 18, the campaign video has been viewed over 1.1 million times.
Did you know Minuum’s campaign is in Indiegogo’s top 10 of all time for projects with the largest number of supporters?
The little keyboard for big fingers, which launched an Indiegogo campaign a week ago today to support the launch of its Android keyboard app and a wearable development kit, is currently less than $4,000 from its crowd-funded stretch goal of $60,000.
The company was featured on CTV News on Mar. 24, 2013. The CTV video story and photos of CEO Will Walmsley and CTO Xavier Snelgrove are available on CTV’s website.
Minuum is a tiny, one-dimensional keyboard that frees up mobile screen space while allowing fast, accurate typing. Its specialized, patent-protected auto-correction algorithm corrects highly imprecise typing.
This algorithm, based on the touchscreen and wearable device research of company founders, Will Walmsley (researcher) and Khai Truong (associate professor) at the University of Toronto, configures the difference between what you type and what you mean, in real time, getting it right even if you miss every single letter.
OtoSim Night revolutionizes how students learn to identify ear pathologies
On Feb. 13, 2013, almost 100 second-year University of Toronto (U of T) medical students participated in an optional, intensive, one-hour otoscopy workshop using the OtoSim™ — a training and simulation system that is radically changing the way students in Canada and around the world learn this poorly-acquired medical skill.
And, if you want to use simulation technology to change the way medical professionals are taught, ear disease is a good place to start.
“Historically, otoscopy simulation involved looking at an image of an eardrum on a piece of film at the end of a rubber ear,” said Dr. Andrew Sinclair, CEO of OtoSim Inc. “OtoSim™ has a digital image bank that is orders of magnitude more extensive. The instructor can electronically point to areas within the image and confirm that the student sees the pathology of interest. Diagnostic accuracy goes up enormously.”
Technology reporter Alastair Charlton speaks to Dr. Raphael Hofstein, president and CEO of MaRS Innovation, about how Tech City in the U.K. can learn from Canada’s hub for science, technology and social entrepreneurs.
Twelve of the 65 participating companies were selected to pitch a group of over 100 chief medical information officers, chief information officers and chief medical officers from U.S. hospitals, along with venture capitalists and industry representatives.